CA 2024 * | 55,18 Md 51,2 Md 49,46 Md | CA 2025 * | 58,14 Md 53,95 Md 52,11 Md | Capitalisation | 299 Md 278 Md 268 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 7,74 Md 7,18 Md 6,94 Md | Résultat net 2025 * | 10,56 Md 9,8 Md 9,46 Md | VE / CA 2024 * | 6,45 x |
Dette nette 2024 * | 56,89 Md 52,79 Md 51 Md | Dette nette 2025 * | 47,91 Md 44,46 Md 42,95 Md | VE / CA 2025 * | 5,97 x |
PER 2024 * |
31,8
x | PER 2025 * |
24,7
x | Employés | - |
Rendement 2024 * |
3,65% | Rendement 2025 * |
3,81% | Flottant | 96,38% |
Dernier transcript sur AbbVie
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Richard Gonzalez
CEO | Chief Executive Officer | 70 | 01/01/13 |
Scott Reents
DFI | Director of Finance/CFO | 57 | 01/01/13 |
Robert Michael
PSD | President | 53 | 01/01/12 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 63 | 01/01/13 |
Edward Rapp
BRD | Director/Board Member | 66 | 01/01/13 |
Director/Board Member | 70 | 01/01/13 |
Nom | PEA | Position | Varia. 1 janv. | Notation |
---|---|---|---|---|
FIDELITY SUST GLB HLTHCARE A-ACC-EUR | Non | 61.23M EUR | +1,00% | |
EURIZON EQUITY WORLD SMART VOL R ACC | Non | 13.7M EUR | +13,00% | |
BGF WORLD HEALTHSCIENCE A2 | Non | 417.49M USD | -2,00% | |
JANUS HENDERSON GLB LIFE SCN I2 USD | Non | 87.56M USD | 0,00% | |
AXA IM US ENHANCED INDEX EQ QI M $ ACC | Non | 25.07M USD | +19,00% |
Varia. 1 janv. | Capi. | |
---|---|---|
+45,82% | 765 Md | |
-6,16% | 354 Md | |
+19,86% | 331 Md | |
+18,45% | 248 Md | |
-0,78% | 219 Md | |
+11,88% | 216 Md | |
+5,90% | 164 Md | |
-0,73% | 162 Md | |
+1,53% | 123 Md |